Intrinsic Value of S&P & Nasdaq Contact Us

Artivion, Inc. AORT NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
60/100
3/7 Pass
SharesGrow Intrinsic Value
$123.97
+226.7%
Analyst Price Target
$52.00
+37%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Artivion, Inc. (AORT) trades at a trailing P/E of 174.4, forward P/E of 105.8. Trailing earnings yield is 0.57%, forward earnings yield 0.94%. PEG 1.49. Graham Number is $6.60.

Criteria proven by this page:

  • VALUE (67/100, Pass) — analyst target implies upside (+37%).
  • Forward P/E 105.8 (down from trailing 174.4) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 1.49 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield 0.57% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 0.94% as earnings recover.
  • Analyst consensus target $52.00 (+37% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 60/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
60/100
SG Score
View full scorecard →
VALUE
67/100
Price-to-Earnings & upside
Proven by this page
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
61/100
→ Income
GROWTH
90/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — AORT

Valuation Multiples
P/E (TTM)174.4
Forward P/E105.8
PEG Ratio1.49
Forward PEG1.49
P/B Ratio3.80
P/S Ratio3.89
EV/EBITDA33.0
Per Share Data
EPS (TTM)$0.21
Forward EPS (Est.)$0.36
Book Value / Share$9.42
Revenue / Share$9.28
FCF / Share$-0.02
Yields & Fair Value
Earnings Yield0.57%
Forward Earnings Yield0.94%
Dividend Yield0.00%
Graham Number$6.60
SharesGrow IV$123.97 (+226.7%)
Analyst Target$52.00 (+37%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 56.6 0.42 2.92 3.38 -
2017 170.7 -2.56 2.27 3.33 -
2018 -262.3 1.31 3.63 3.80 -
2019 584.6 -4.12 3.52 3.64 -
2020 -53.6 0.05 2.72 3.53 -
2021 -53.5 3.92 2.64 2.65 -
2022 -25.3 -0.96 1.71 1.55 -
2023 -23.7 -0.42 2.59 2.06 -
2024 -89.2 1.56 4.31 3.07 -
2025 211.7 -1.25 4.61 4.69 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.32 $180.38M $10.78M 6%
2017 $0.11 $189.7M $3.7M 2%
2018 $-0.10 $262.84M $-3.81M -1.4%
2019 $0.05 $276.22M $1.72M 0.6%
2020 $-0.44 $253.23M $-16.68M -6.6%
2021 $-0.38 $298.84M $-14.83M -5%
2022 $-0.48 $313.79M $-19.19M -6.1%
2023 $-0.75 $354M $-30.69M -8.7%
2024 $-0.32 $388.54M $-13.36M -3.4%
2025 $0.21 $441.33M $9.77M 2.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.36 $0.35 – $0.36 $494.14M $493.74M – $494.54M 4
2027 $0.76 $0.75 – $0.76 $549.38M $548.09M – $550.68M 4
2028 $0.87 $0.76 – $0.97 $616.15M $609.01M – $619.55M 2
2029 $1.33 $1.31 – $1.34 $697.9M $689.81M – $701.75M 1
2030 $1.72 $1.69 – $1.73 $787.3M $778.17M – $791.65M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message